Low CD39 Expression on B Cells Predicts the Occurrence of Anti-Drug Antibodies in RA Patients Treated with Rituximab

Samuel Bitoun; Bineta Ly; Signe Hässler; Audrey Paoletti; Aude Gleizes; Salima Hacein-Bey; Philippe Bröet; Marc Pallardy; Xavier Mariette

Conference Poster Year : 2021

Low CD39 Expression on B Cells Predicts the Occurrence of Anti-Drug Antibodies in RA Patients Treated with Rituximab

, , (1) , , , , , ,

1

Samuel Bitoun

Function : Author

Bineta Ly

Function : Author

Signe Hässler

Function : Author

Immunologie - Immunopathologie - Immunothérapie [CHU Pitié Salpêtrière]

Audrey Paoletti

Function : Author

Aude Gleizes

Function : Author

Salima Hacein-Bey

Function : Author

Philippe Bröet

Function : Author

Marc Pallardy

Function : Author
PersonId : 1303183
ORCID : 0000-0001-8869-0365
IdRef : 069273227

Xavier Mariette

Function : Author
PersonId : 756829
ORCID : 0000-0002-4244-5417
IdRef : 113094116

Keywords

B-Lymphocyte Biologicals immunology rheumatoid arthritis B-Lymphocyte Biologicals immunology rheumatoid arthritis

Domains

Immunology Rhumatology and musculoskeletal system Santé publique et épidémiologie

Signe Hässler : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-03978739

Submitted on : Wednesday, February 8, 2023-1:39:46 PM

Last modification on : Thursday, April 18, 2024-11:02:10 AM

Dates and versions

hal-03978739 , version 1 (08-02-2023)

Identifiers

HAL Id : hal-03978739 , version 1

Cite

Samuel Bitoun, Bineta Ly, Signe Hässler, Audrey Paoletti, Aude Gleizes, et al.. Low CD39 Expression on B Cells Predicts the Occurrence of Anti-Drug Antibodies in RA Patients Treated with Rituximab. ACR Convergence 2021, Nov 2021, Virtual (Online), United States. ⟨hal-03978739⟩

Low CD39 Expression on B Cells Predicts the Occurrence of Anti-Drug Antibodies in RA Patients Treated with Rituximab

Keywords

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Share